Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBLT | ABVC | AKTX | ||
| Company | Vascular Biogen. Ord | Abvc Biopharma Inc | Akari Therapeutics ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.0690 | 1.1500 | 1.5800 | ||
| High | 6.7375 | 1.1500 | 1.5900 | ||
| Low | 5.3410 | 1.0700 | 1.3300 | ||
| Last | 5.4600 | 1.0800 | 1.3600 | ||
| Change | -0.5250 | -0.0700 | -0.1100 | ||
| % Change | -8.77% | -6.09% | -7.48% | ||
| Volume | 161,505 | 415,900 | 20,700 | ||
| 20-Day Average Volume | 1,006,195 | 1,738,515 | 23,150 | ||
| Previous Close | 5.9850 | 1.1500 | 1.4700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2249 | 1.1985 | 1.2741 | ||
| 20-Day Raw Stochastic | 2.51% | 17.72% | 35.75% | ||
| 20-Day Relative Strength | 35.56% | 44.74% | 43.31% | ||
| Weighted Alpha | +1.00 | -85.81 | -63.47 | ||
| Today's Opinion | 40% Sell | 96% Sell | 72% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 24% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -33.76% since 10/09/23 | -23.94% since 04/26/24 | +14.77% since 04/26/24 | ||
| Low | 0.1526 on 10/16/23 | 1.0500 on 05/01/24 | 1.1800 on 04/29/24 | ||
| High | 0.2880 on 10/12/23 | 1.4499 on 04/29/24 | 1.8676 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -33.33% since 09/15/23 | -16.28% since 04/03/24 | -12.26% since 04/03/24 | ||
| Low | 0.1526 on 10/16/23 | 0.9400 on 04/18/24 | 1.0775 on 04/17/24 | ||
| High | 0.2880 on 10/12/23 | 1.7300 on 04/25/24 | 1.8676 on 05/02/24 | ||
| 3-Month | |||||
| %Chg | -46.99% since 07/14/23 | -28.00% since 02/02/24 | -45.38% since 02/02/24 | ||
| Low | 0.1526 on 10/16/23 | 0.9400 on 04/18/24 | 1.0775 on 04/17/24 | ||
| High | 0.3098 on 07/25/23 | 1.7300 on 04/25/24 | 2.6352 on 02/06/24 | ||
| 6-Month | |||||
| %Chg | -20.93% since 04/14/23 | -7.69% since 11/03/23 | -62.33% since 11/03/23 | ||
| Low | 0.1520 on 04/25/23 | 0.9400 on 04/18/24 | 1.0775 on 04/17/24 | ||
| High | 0.3200 on 07/13/23 | 2.4500 on 01/03/24 | 3.6850 on 11/06/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,112 | 12,144 | 11,648 | ||
| Shares Outstanding, K | 77,640 | 10,560 | 7,924 | ||
| Annual Sales | 660,000 | 150,000 | 0 | ||
| Annual Net Income | -32,300,000 | -10,520,000 | -10,010,000 | ||
| Last Quarter Sales | 0 | 20,000 | 0 | ||
| Last Quarter Net Income | -870,000 | -3,320,000 | -5,680,000 | ||
| 60-Month Beta | 0.76 | 0.75 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 08/14/23 | -0.35 on 03/13/24 | N/A on 09/27/22 | ||
| Latest Earnings Date | 11/13/23 | 05/20/24 | 05/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||